Your trusted resource for people with allergies, asthma, and related conditions
and for those who care for them
Allergy & Asthma Network unites and advocates on behalf of 60 million Americans with asthma, allergies, and related conditions.
Bulletin Board
February 10, 2026
Launching the Patient Advocacy Leadership Initiative (PALI)
PALI is a multifaceted program supporting a network of informed, empowered patient advocates to influence healthcare policy at federal, state and local levels. Advocates attend monthly virtual interactive meetings to learn how to get involved. PALI is an “investment in the power of a strong, connected advocacy community,” CEO Lynda Mitchell says.
Allergy & Asthma Network’s CEO Offers Perspective on Sublingual Epinephrine
CEO Lynda Mitchell shared her insight with Healio on FDA’s recent pause of Anaphylm®, the new under-the-tongue epinephrine strip of film from Aquestive. When approved, the product will improve patient access and everyday anaphylaxis readiness. “A lot of people are hesitant to use an auto-injector, so a needle-free option is a really important step,” Lynda said.
Allergy & Asthma Network’s Researchers Examine Macrolides in Asthma Care
Chief Research Officer De De Gardner and patient advocates Angel Melendez and Hilarry Orr were among co-authors of a new study on macrolide antibiotics in asthma care. Published in the Journal of Allergy and Clinical Immunology, the research found that macrolides reduced severe asthma attacks and improved quality of life, pointing to a promising new direction for asthma treatment.
Allergy & Asthma in the News
Podcasts
A New Treatment for Chronic Hives: Remibrutinib
How to Treat Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
How to Improve Indoor Air Quality for Asthma
Recent & Upcoming Webinars
Check out our Events Calendar for Webinars, Trusted Messengers Events, and other Allergy & Asthma Network supported events.









